Literature DB >> 7999473

Trends in breast cancer in younger women in contrast to older women.

B F Hankey1, B Miller, R Curtis, C Kosary.   

Abstract

Using data from the Surveillance, Epidemiology, and End Results (SEER) Program and the National Center for Health Statistics, trends in female breast cancer rates were examined for the time period 1973-1989 for the age group 20-39 and contrasted with those for older ages. Only about 7% of breast cancers occur by the age of 40; the risk of developing breast cancer prior to the age of 40 is less than 1%. The incidence trends for women in the 20-39 age group have been essentially stable, whereas for women 40 and older the rates increased steeply during the 1980s (at a faster rate than anticipated based on historical trends) and then leveled off beginning in 1987. Breast cancer mortality has been much more stable over time than incidence. Up to age 40, blacks have a higher incidence than whites. Over age 40, white rates exceed those for blacks, and the absolute and relative differences in incidence increase with advancing age. For whites, 5-year relative survival rates improved with advancing age up to age 50. Blacks under the age of 30 had survival rates similar to whites, whereas, in the older age groups, whites had somewhat better survival rates overall and by stage. The occurrence of second cancers was also analyzed in women with a first invasive breast cancer. Cancers found to occur at higher than expected rates included leukemia and cancers of the breast, ovary, and lung.

Entities:  

Mesh:

Year:  1994        PMID: 7999473

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  20 in total

Review 1.  Mammographic screening in older women. Is it worthwhile?

Authors:  J A van Dijck; M J Broeders; A L Verbeek
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

2.  Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer.

Authors:  Q Gao; S Neuhausen; S Cummings; M Luce; O I Olopade
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

3. 

Authors:  G Schüler; F Gutzwiller
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

4.  GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation.

Authors:  Kutluk Oktay; Ilgın Türkçüoğlu; Kenny A Rodriguez-Wallberg
Journal:  Reprod Biomed Online       Date:  2010-03-06       Impact factor: 3.828

5.  FISH detection of HER-2/neu oncogene amplification in early onset breast cancer.

Authors:  W R Xing; K W Gilchrist; C P Harris; W Samson; L F Meisner
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 6.  Organochlorine compounds and estrogen-related cancers in women.

Authors:  H O Adami; L Lipworth; L Titus-Ernstoff; C C Hsieh; A Hanberg; U Ahlborg; J Baron; D Trichopoulos
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

7.  Is breast cancer in young Asian women more aggressive than in Caucasians? A cross-sectional analysis.

Authors:  Muy-Kheng M Tea; Lei Fan; James W Delancey; Christine Staudigl; Stefan Steurer; Christina Lang; Zhi-Ming Shao; Christian F Singer
Journal:  Tumour Biol       Date:  2013-04-13

8.  Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.

Authors:  Wen-Bin Zhou; Hong Yin; Xiao-An Liu; Xiao-Ming Zha; Lin Chen; Jun-Cheng Dai; Ai-di Tao; Ling Chen; Jing-Jing Ma; Li-Jun Ling; Shui Wang
Journal:  BMC Cancer       Date:  2010-06-11       Impact factor: 4.430

9.  Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer.

Authors:  Megan Greally; Jennifer Kielty; Geoffrey A Watson; Geoffrey Das; Christina Malouf; Lynda McSorley; Niamh Coleman; Cecily Quinn; Enda W McDermott; Giuseppe Gullo; John Crown; Ruth S Prichard; Catherine M Kelly; Janice M Walshe
Journal:  Ir J Med Sci       Date:  2018-05-15       Impact factor: 1.568

Review 10.  The role of ovarian ablation in the adjuvant therapy of breast cancer.

Authors:  Sing-Huang Tan; Antonio C Wolff
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.